Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Current Taxes: 2010-2025

Historic Current Taxes for China Pharma Holdings (CPHI) over the last 3 years, with Sep 2025 value amounting to $691,677.

  • China Pharma Holdings' Current Taxes rose 73.26% to $691,677 in Q3 2025 from the same period last year, while for Sep 2025 it was $691,677, marking a year-over-year increase of 73.26%. This contributed to the annual value of $595,476 for FY2024, which is 42.03% down from last year.
  • According to the latest figures from Q3 2025, China Pharma Holdings' Current Taxes is $691,677, which was down 6.70% from $741,376 recorded in Q2 2025.
  • In the past 5 years, China Pharma Holdings' Current Taxes registered a high of $1.0 million during Q4 2023, and its lowest value of $399,212 during Q3 2024.
  • Its 3-year average for Current Taxes is $668,345, with a median of $643,576 in 2024.
  • As far as peak fluctuations go, China Pharma Holdings' Current Taxes plummeted by 42.03% in 2024, and later surged by 73.26% in 2025.
  • Over the past 3 years, China Pharma Holdings' Current Taxes (Quarterly) stood at $1.0 million in 2023, then tumbled by 42.03% to $595,476 in 2024, then skyrocketed by 73.26% to $691,677 in 2025.
  • Its last three reported values are $691,677 in Q3 2025, $741,376 for Q2 2025, and $555,142 during Q1 2025.